The US spends substantially more on health care per capita and as a percentage of its economy than any other country in the world,1 and this gap has widened substantially in recent decades. In the JAMA theme issue devoted to prescription drug pricing, a study by Dieleman and colleagues2 charts US health care spending by payer and health condition from 1996 through 2016. This study adds clinical insights and more recent data to prior reports of US spending trends published by the same research group in JAMA.3,4
The authors analyzed a wide range of health care data sources maintained by the federal government. These sources represented 85.2% of all US health care spending during the study period, with spending excluded for home health services, durable medical equipment, and nonprescription medications.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
John Z. Ayanian, MD, MPP Dr John Ayanian is the inaugural Director of the Institute for Healthcare Policy and Innovation at the University of Michigan, the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy, Professor of Health Management...